Loading...
XSHE000931
Market cap466mUSD
Jan 09, Last price  
4.54CNY
1D
-0.44%
1Q
-0.44%
Jan 2017
-46.40%
Name

Beijing Centergate Technologies Holding Co Ltd

Chart & Performance

D1W1MN
XSHE:000931 chart
P/E
70.09
P/S
1.50
EPS
0.06
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
5.12%
Revenues
2.28b
+10.50%
1,324,817,056505,770,543488,813,8082,232,309,1812,056,061,3122,329,444,6762,599,059,5183,310,476,8703,270,537,0223,605,177,8513,034,196,9251,078,026,3191,478,567,3571,740,701,0551,773,506,8042,135,149,0421,789,615,9001,955,834,3892,060,280,7072,276,603,345
Net income
49m
57,949,27304,191,42489,018,19960,527,67749,919,15810,461,78041,637,63829,888,445013,750,904152,389,92927,358,13814,261,57993,140,19495,218,08755,389,0080048,781,604
CFO
218m
+18.81%
244,349,147233,410,6790720,544,525196,034,807186,229,097183,584,205243,578,9600497,422,724000158,797,288205,222,888164,165,782200,200,020263,413,088183,742,331218,298,525
Dividend
Jul 17, 20020.086207 CNY/sh
Earnings
May 09, 2025

Profile

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical production and sales, construction, real estate development, and property management businesses in China and internationally. The company offers huasu west-ground iodine, fesser phenylcycline hydrochloride, bosu fuma acid bisolol, yuanji beni flat hydrochloric acid, naloxone hydrochloride, five plus biochemical, and aramol quramado tablets and capsules. It also provides mucous membrane repair and oral health care products, including toothpaste, mouthwash, spray, dental equipment, and other oral care products for ulcers, burns, mechanical damage, and postoperative repair; and fruit enzymes, imported fungella enzymes, functional probiotics, and soda and other edible grade raw materials. In addition, the company invests in software technology, communications and electronic engineering, biomedicine, and life sciences and other fields. Beijing Centergate Technologies (holding) Co., Ltd. was founded in 1999 and is based in Beijing, China.
URL
http://www.centek.com.cn
IPO date
Jul 12, 1999
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,276,603
10.50%
2,060,281
5.34%
Cost of revenue
1,940,972
1,788,704
Unusual Expense (Income)
NOPBT
335,631
271,577
NOPBT Margin
14.74%
13.18%
Operating Taxes
21,683
21,932
Tax Rate
6.46%
8.08%
NOPAT
313,948
249,645
Net income
48,782
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
391,407
459,806
Long-term debt
710,319
900,721
Deferred revenue
17,650
18,248
Other long-term liabilities
52,790
11,917
Net debt
901,929
1,227,343
Cash flow
Cash from operating activities
218,299
183,742
CAPEX
(67,323)
Cash from investing activities
(117,473)
Cash from financing activities
(34,689)
FCF
444,429
373,112
Balance
Cash
194,248
126,110
Long term investments
5,550
7,074
Excess cash
85,967
30,170
Stockholders' equity
105,394
1,089,673
Invested Capital
2,476,645
2,584,101
ROIC
12.41%
9.43%
ROCE
12.67%
10.37%
EV
Common stock shares outstanding
752,803
753,127
Price
5.87
-4.55%
6.15
-19.82%
Market cap
4,418,951
-4.59%
4,631,731
-19.82%
EV
5,522,660
6,049,143
EBITDA
509,977
410,253
EV/EBITDA
10.83
14.74
Interest
58,792
65,732
Interest/NOPBT
17.52%
24.20%